AR078916A1 - Procedimiento para la purificacion de paliperidona - Google Patents

Procedimiento para la purificacion de paliperidona

Info

Publication number
AR078916A1
AR078916A1 ARP100104099A ARP100104099A AR078916A1 AR 078916 A1 AR078916 A1 AR 078916A1 AR P100104099 A ARP100104099 A AR P100104099A AR P100104099 A ARP100104099 A AR P100104099A AR 078916 A1 AR078916 A1 AR 078916A1
Authority
AR
Argentina
Prior art keywords
procedure
paliperidona
purification
compound
formula
Prior art date
Application number
ARP100104099A
Other languages
English (en)
Inventor
Diego Ghisleri
Marcello Rasparini
Original Assignee
Chemo Iberica Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Iberica Sa filed Critical Chemo Iberica Sa
Publication of AR078916A1 publication Critical patent/AR078916A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

El procedimiento comprende someter la paliperidona cruda a una reaccion de esterificacion en presencia de un agente básico para obtener un compuesto de formula (3), en donde n es 1-8. Este procedimiento proporciona paliperidona con una pureza elevada. Reivindicacion 11: Un compuesto de formula (3), o una sal farmacéuticamente aceptable del mismo en donde n es 1-8.
ARP100104099A 2009-12-01 2010-11-04 Procedimiento para la purificacion de paliperidona AR078916A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09382266A EP2343296A1 (en) 2009-12-01 2009-12-01 A process for the purification of paliperidone

Publications (1)

Publication Number Publication Date
AR078916A1 true AR078916A1 (es) 2011-12-14

Family

ID=42083889

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP100104099A AR078916A1 (es) 2009-12-01 2010-11-04 Procedimiento para la purificacion de paliperidona

Country Status (3)

Country Link
EP (1) EP2343296A1 (es)
AR (1) AR078916A1 (es)
WO (1) WO2011067220A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102274164B (zh) * 2011-08-22 2014-07-02 长春健欣生物医药科技开发有限公司 帕潘立酮及帕潘立酮衍生物的注射用缓释凝胶剂
WO2013080220A2 (en) * 2011-11-28 2013-06-06 Davuluri Rammohan Rao An improved process for the preparation of 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydio-9-hydroxy-2-methyl-4h-pyrido[1,2-a]pyrimidin-4-one.
CN104736567B (zh) 2012-08-21 2019-09-03 詹森药业有限公司 阿立哌唑半抗原的抗体及其用途
US9504682B2 (en) 2012-08-21 2016-11-29 Janssen Pharmaceutica Nv Haptens of aripiprazole
JP6286429B2 (ja) 2012-08-21 2018-02-28 ヤンセン ファーマシューティカ エヌ．ベー． パリペリドンのハプテン
ES2926662T3 (es) 2012-08-21 2022-10-27 Janssen Pharmaceutica Nv Anticuerpos contra haptenos de risperidona y uso de los mismos
ES2691092T3 (es) 2012-08-21 2018-11-23 Janssen Pharmaceutica Nv Anticuerpos contra la risperidona y uso de los mismos
JP2015529199A (ja) 2012-08-21 2015-10-05 オルソ−クリニカル ダイアグノスティクス，インコーポレイティド パリペリドンハプテンに対する抗体及びその使用
CN108640996A (zh) 2012-08-21 2018-10-12 詹森药业有限公司 帕潘立酮的抗体及其用途
EP3390449A1 (en) 2015-12-17 2018-10-24 Janssen Pharmaceutica N.V. Antibodies to risperidone and use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2000786C (en) 1988-11-07 1999-01-26 Cornelus G. M. Janssen 3-piperidinyl-1,2-benzisoxazoles
WO2008021346A2 (en) 2006-08-14 2008-02-21 Teva Pharmaceutical Industries Ltd. Pure paliperidone and processes for preparing thereof
US20080171876A1 (en) * 2007-05-10 2008-07-17 Santiago Ini Pure paliperidone and processes for preparing thereof
WO2009010988A1 (en) * 2007-07-19 2009-01-22 Natco Pharma Limited An improved, industrially viable process for the preparation of high purity paliperidone
WO2009016653A1 (en) * 2007-07-31 2009-02-05 Natco Pharma Limited Stable polymorphic form of paliperidone and process for its preparation
US20090048272A1 (en) 2007-08-16 2009-02-19 Pratap Reddy Padi Preparation of paliperidone
US20090061005A1 (en) * 2007-08-21 2009-03-05 Actavis Group Ptc Ehf Paliperidone Polymorphs
US20100298566A1 (en) 2007-11-07 2010-11-25 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of paliperidone and its intermediates
BRPI0905938A2 (pt) 2008-02-05 2018-05-29 Watson Pharma Private Ltd processo para preparação de 3-(2 cloroetil)- 2- metil hidróxi- 4h-pirido [l, 2-a] pirimidina-4- ona, de 3- (2-cloroetil)-6,7,8,9- tetraidro 9- hidróxil-2-metil-4h-pirido[1,2-a]pirimidina-4-ona, de 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-il)-1-piperidinil]etil]-6,7,8,9-tetaidro-9-hidróxi-2-metil-4h-pirido[1,2-a]pirimidina-4-ona bruta, e processo para a purificação da paliperidona
WO2009118655A2 (en) * 2008-03-27 2009-10-01 Actavis Group Ptc Ehf Highly pure paliperidone or a pharmaceutically acceptable salt thereof substantially free of keto impurity

Also Published As

Publication number Publication date
WO2011067220A1 (en) 2011-06-09
EP2343296A1 (en) 2011-07-13

Similar Documents

Publication Publication Date Title
AR078916A1 (es) Procedimiento para la purificacion de paliperidona
ES2634490T3 (es) Derivados de ácido napht-2-ylacetico para tratar el sida
JOP20210064A1 (ar) عملية لتحضير 5- فلورو-1h- بيرازولوبيريدينات مستبدلة
CR20130534A (es) Nuevos derivados de imidazol útiles para el tratamiento de artritis
IN2014MN02106A (es)
CO6430426A2 (es) Compuestos de triazolopiridina, y su accion comominhibidor de prolil hidroxilasa e inductor de la produccion de eritropoyetina
AR076027A1 (es) Metodos e intermediarios para la preparacion de agentes farmaceuticos
AR085155A1 (es) Procesos para preparar compuestos de quinolina y composiciones farmaceuticas que contienen dichos compuestos
AR092278A1 (es) Proceso de obtencion de derivados n-acilicos de bifenil-alanina e intermediarios relacionados
CO6551666A2 (es) Macrociclos como inhibidores del factor de coagulacion (fxia)
CR20110343A (es) Inhibidores de proteína cinasa
UY35641A (es) PROCEDIMIENTO DE SÍNTESIS PARA PREPARAR ANÁLOGOS MACROCÍCLICOS C1-CETO DE HALICONDRINA B, E INTERMEDIARIOS ÚTILES INCLUYENDO INTERMEDIARIOS CONTENIENDO GRUPOS ?SO2-(p-TOLILO)
ECSP14013239A (es) Composiciones farmacéuticas
CO6670566A2 (es) Derivados de tetrahidro- pirido-pirimidina
AR074845A1 (es) Procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable
IN2014MN01521A (es)
MX2013000295A (es) Procedimiento de preparacion de un inhibidor especifico de la trombina.
UY33325A (es) Purificación mediante adsorción de colorante caramelo
CL2011000296A1 (es) Proceso de preparación del ester metílico del ácido 4-oxo-octahidro-indol-1-carboxílico y compuestos intermediarios utilizados.
PT2462098E (pt) Processos para a preparação de derivados de ácido 1-(2- halobifenil-4-il)-ciclopropanocarboxílico
AR084864A1 (es) Proceso de preparacion de girasa e inhibidores de topoisomerasa iv y compuestos intermediarios de dicho proceso
BR112012017845A2 (pt) novo processo para produção de derivados de benzofenona
AR086987A1 (es) 1-piperazino-3-fenil-indanos deuterados para el tratamiento de esquizofrenia
MX2013002620A (es) Novedosas n-hidroxi-benzamidas para el tratamiento del cancer.
MX2013000294A (es) Intermedios y procedimiento de preparación de un inhibidor específico de la trombina.

Legal Events

Date Code Title Description
FB Suspension of granting procedure